Genomics and Population Health Action Collaborative
Population Screening Group
The Population Screening Working Group focused on methods to identify otherwise healthy individuals who carry a pathogenic variant that puts them at substantially elevated risk for cancer and heart disease.
|James Evans, M.D., Ph.D.
Bryson Distinguished Professor of Genetics & Medicine
Director, Adult and Cancer Clinical Genetics
UNC School of Medicine
Michael Murray, M.D.
Director of Clinical Operations, Center for Genomic Health
Yale University School of Medicine
Participants in this group developed a discussion paper that outlines a number of considerations for implementing genomics-based screening programs for healthy adults.
The Genomics and Population Health Action Collaborative, is an ad hoc activity under the auspices of the Roundtable on Genomics and Precision Health at the National Academies of Sciences, Engineering, and Medicine (the National Academies). The products of the action collaborative do not necessarily represent the views of any one organization, the Roundtable, or the National Academies and have not been subjected to the review procedures of, nor are they a report or product of, the National Academies.
For more information about the Genomics and Population Health Action Collaborative, please click here.